Advertisement
Screener

INOVIO PHARMACEUTICALS, INC. (INO) Increase (Decrease) in Accounts Payable, Related Parties

2.8 / 5 stars · 68/120 Roast Me

INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable, Related Parties

INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Accounts Payable, Related Parties of $859.35 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2022-05-10

  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2022-03-31 was $859.35K, a 585.88% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-12-31 was $56.39K.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-09-30 was -$1.28M, a 553.11% decline year-over-year.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2021-06-30 was $1.01M, a 113.54% increase year-over-year.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2021 was -$94.94K, a 169.99% decline from fiscal 2020.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2020 was $135.65K.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2019 was -$248.06K, a 587.84% decline from fiscal 2018.
  • INOVIO PHARMACEUTICALS, INC. increase (decrease) in accounts payable, related parties for fiscal 2018 was $50.85K.
Period endIncrease (Decrease) in Accounts Payable, Related Parties 3 monthIncrease (Decrease) in Accounts Payable, Related Parties 6 monthIncrease (Decrease) in Accounts Payable, Related Parties 9 monthIncrease (Decrease) in Accounts Payable, Related Parties 12 month
2022-03-31$859.35K
10-Q · filed 2022-05-10
$915.74K
derived: sum of 2 quarters · filed 2022-05-10
-$366.46K
derived: sum of 3 quarters · filed 2022-05-10
$639.13K
derived: sum of 4 quarters · filed 2022-05-10
2021-12-31$56.39K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$1.23M
derived: sum of 2 quarters · filed 2022-03-01
-$220.23K
derived: sum of 3 quarters · filed 2022-03-01
-$94.94K
10-K · filed 2022-03-01
2021-09-30-$1.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$276.62K
derived: sum of 2 quarters · filed 2021-11-09
-$151.32K
10-Q · filed 2021-11-09
-$303.28K
derived: sum of 4 quarters · filed 2022-05-10
2021-06-30$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$1.13M
10-Q · filed 2021-08-09
$978.92K
derived: sum of 3 quarters · filed 2022-05-10
$1.26M
derived: sum of 4 quarters · filed 2022-05-10
2021-03-31$125.29K
10-Q · filed 2022-05-10
-$26.67K
derived: sum of 2 quarters · filed 2022-05-10
$256.31K
derived: sum of 3 quarters · filed 2022-05-10
$727.22K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$151.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$131.02K
derived: sum of 2 quarters · filed 2022-03-01
$601.92K
derived: sum of 3 quarters · filed 2022-03-01
$135.65K
10-K · filed 2022-03-01
2020-09-30$282.98K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$753.88K
derived: sum of 2 quarters · filed 2021-11-09
$287.61K
10-Q · filed 2021-11-09
$554.74K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$470.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$4.63K
10-Q · filed 2021-08-09
$271.77K
derived: sum of 3 quarters · filed 2022-03-01
$80.80K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$466.27K
10-Q · filed 2021-05-10
-$199.14K
derived: sum of 2 quarters · filed 2022-03-01
-$390.11K
derived: sum of 3 quarters · filed 2022-03-01
-$1.05M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$267.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$76.16K
derived: sum of 2 quarters · filed 2022-03-01
-$585.88K
derived: sum of 3 quarters · filed 2022-03-01
-$248.06K
10-K · filed 2022-03-01
2019-09-30-$190.97K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$853.01K
derived: sum of 2 quarters · filed 2020-11-09
-$515.20K
10-Q · filed 2020-11-09
-$228.32K
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30-$662.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$324.22K
10-Q · filed 2020-08-10
-$37.35K
derived: sum of 3 quarters · filed 2021-03-01
$52.87K
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$337.82K
10-Q · filed 2020-05-11
$624.69K
derived: sum of 2 quarters · filed 2021-03-01
$714.91K
derived: sum of 3 quarters · filed 2021-03-01
$16.87K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$286.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$377.09K
derived: sum of 2 quarters · filed 2021-03-01
-$320.95K
derived: sum of 3 quarters · filed 2021-03-01
$50.85K
10-K · filed 2021-03-01
2018-09-30$90.22K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$607.82K
derived: sum of 2 quarters · filed 2019-11-12
-$236.02K
10-Q · filed 2019-11-12
-$91.96K
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$698.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$326.24K
10-Q · filed 2019-08-08
-$182.18K
derived: sum of 3 quarters · filed 2020-03-12
-$246.72K
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$371.80K
10-Q · filed 2019-05-09
$515.86K
derived: sum of 2 quarters · filed 2020-03-12
$451.32K
derived: sum of 3 quarters · filed 2020-03-12
$769.57K
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31$144.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$79.52K
derived: sum of 2 quarters · filed 2020-03-12
$397.77K
derived: sum of 3 quarters · filed 2020-03-12
-$145.64K
10-K · filed 2020-03-12
2017-09-30-$64.54K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$253.71K
derived: sum of 2 quarters · filed 2018-11-08
-$289.70K
10-Q · filed 2018-11-08
$289.46K
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30$318.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07
-$225.16K
10-Q · filed 2018-08-07
$354.00K
derived: sum of 3 quarters · filed 2019-03-12
$246.45K
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31-$543.41K
10-Q · filed 2018-05-09
$35.75K
derived: sum of 2 quarters · filed 2019-03-12
-$71.80K
derived: sum of 3 quarters · filed 2019-03-12
$321.94K
derived: sum of 4 quarters · filed 2019-03-12
2016-12-31$579.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$471.61K
derived: sum of 2 quarters · filed 2019-03-12
$865.35K
derived: sum of 3 quarters · filed 2019-03-12
$907.53K
10-K · filed 2019-03-12
2016-09-30-$107.55K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$286.19K
derived: sum of 2 quarters · filed 2017-11-08
$328.37K
10-Q · filed 2017-11-08
-$2.32M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$393.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$435.92K
10-Q · filed 2017-08-08
-$2.21M
derived: sum of 3 quarters · filed 2018-03-14
-$2.82M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$42.19K
10-Q · filed 2017-05-10
-$2.61M
derived: sum of 2 quarters · filed 2018-03-14
-$3.21M
derived: sum of 3 quarters · filed 2018-03-14
$202.23K
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$2.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$3.25M
derived: sum of 2 quarters · filed 2018-03-14
$160.05K
derived: sum of 3 quarters · filed 2018-03-14
$136.64K
10-K · filed 2018-03-14
2015-09-30-$604.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$2.81M
derived: sum of 2 quarters · filed 2016-11-09
$2.78M
10-Q · filed 2016-11-09
$2.72M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30$3.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$3.39M
10-Q · filed 2016-08-08
$3.32M
derived: sum of 3 quarters · filed 2017-03-15
$2.71M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$23.41K
10-Q · filed 2016-05-09
-$89.25K
derived: sum of 2 quarters · filed 2017-03-15
-$699.50K
derived: sum of 3 quarters · filed 2017-03-15
-$774.50K
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31-$65.84K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
-$676.09K
derived: sum of 2 quarters · filed 2017-03-15
-$751.09K
derived: sum of 3 quarters · filed 2017-03-15
-$493.85K
10-K · filed 2017-03-15
2014-09-30-$610.25K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$685.25K
derived: sum of 2 quarters · filed 2015-11-09
-$428.00K
10-Q · filed 2015-11-09
-$400.21K
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30-$75.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$182.25K
10-Q · filed 2015-08-10
$210.04K
derived: sum of 3 quarters · filed 2016-03-14
$659.21K
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31$257.25K
10-Q · filed 2015-05-11
$285.04K
derived: sum of 2 quarters · filed 2016-03-14
$734.21K
derived: sum of 3 quarters · filed 2016-03-14
$401.77K
derived: sum of 4 quarters · filed 2016-03-14
2013-12-31$27.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$476.97K
derived: sum of 2 quarters · filed 2016-03-14
$144.52K
derived: sum of 3 quarters · filed 2016-03-14
$334.98K
10-K · filed 2016-03-14
2013-09-30$449.17K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$116.73K
derived: sum of 2 quarters · filed 2014-11-10
$307.19K
10-Q · filed 2014-11-10
$384.36K
derived: sum of 4 quarters · filed 2015-03-16
2013-06-30-$332.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
-$141.99K
10-Q · filed 2014-08-11
-$64.81K
derived: sum of 3 quarters · filed 2015-03-16
-$8.33K
derived: sum of 4 quarters · filed 2015-03-16
2013-03-31$190.46K
10-Q · filed 2014-05-12
$267.63K
derived: sum of 2 quarters · filed 2015-03-16
$324.12K
derived: sum of 3 quarters · filed 2015-03-16
$295.57K
derived: sum of 4 quarters · filed 2015-03-16
2012-12-31$77.17K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16
$133.66K
derived: sum of 2 quarters · filed 2015-03-16
$105.12K
derived: sum of 3 quarters · filed 2015-03-16
$166.93K
10-K · filed 2015-03-16
2012-09-30$56.49K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$27.94K
derived: sum of 2 quarters · filed 2013-11-12
$89.76K
10-Q · filed 2013-11-12
-$496.65K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$28.55K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$33.27K
10-Q · filed 2013-08-09
-$553.14K
derived: sum of 3 quarters · filed 2014-03-17
-$703.88K
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$61.81K
10-Q · filed 2013-05-10
-$524.60K
derived: sum of 2 quarters · filed 2014-03-17
-$675.33K
derived: sum of 3 quarters · filed 2014-03-17
-$587.22K
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$586.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$737.14K
derived: sum of 2 quarters · filed 2014-03-17
-$649.04K
derived: sum of 3 quarters · filed 2014-03-17
-$1.66M
10-K · filed 2014-03-17
2011-09-30-$150.73K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07
-$62.63K
derived: sum of 2 quarters · filed 2012-11-07
-$1.07M
10-Q · filed 2012-11-07
$128.99K
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$88.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$923.46K
10-Q · filed 2012-08-09
$279.72K
derived: sum of 3 quarters · filed 2013-03-18
$422.11K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$1.01M
10-Q · filed 2012-05-09
$191.61K
derived: sum of 2 quarters · filed 2013-03-18
$334.00K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$1.35M
derived: sum of 2 quarters · filed 2013-03-18
$1.24M
10-K · filed 2013-03-18
2010-09-30$142.39K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$32.68K
10-Q · filed 2011-11-07
2010-06-30-$109.71K
10-Q · filed 2011-08-05
2009-12-31$428.35K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
MEDICINOVA INC (MNOV)United States$0.130B-6.04
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Immuneering Corp (IMRX)United States$0.113B-12.51